Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,305 INR | -2.16% | -1.09% | +33.66% |
04-22 | Epigral's Consolidated Profit Climbs in Fiscal Q4; Shares Up 4% | MT |
04-22 | Epigral Limited Recommends Final Dividend for the Financial Year Ended March 31, 2024 | CI |
Sales 2022 | 15.51B 186M 14.89B | Sales 2023 | 21.88B 262M 21.01B | Capitalization | 39.21B 470M 37.65B |
---|---|---|---|---|---|
Net income 2022 | 2.53B 30.32M 2.43B | Net income 2023 | 3.53B 42.37M 3.39B | EV / Sales 2022 | 3.23 x |
Net Debt 2022 | 9.68B 116M 9.29B | Net Debt 2023 | 8.65B 104M 8.31B | EV / Sales 2023 | 2.19 x |
P/E ratio 2022 |
16
x | P/E ratio 2023 |
11.1
x | Employees | 936 |
Yield 2022 * |
-
| Yield 2023 |
0.53% | Free-Float | 28.59% |
1 day | -2.16% | ||
1 week | -1.09% | ||
Current month | +19.05% | ||
1 month | +20.48% | ||
3 months | +30.73% | ||
6 months | +44.78% | ||
Current year | +33.66% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 39 | 17/05/17 | |
Director of Finance/CFO | - | 06/05/14 | |
Chairman | 41 | 31/03/17 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 60 | - | |
Chairman | 41 | 31/03/17 | |
Director/Board Member | 37 | 09/05/16 |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 1,305 | -2.16% | 13,022 |
25/04/24 | 1,334 | -0.78% | 3,624 |
24/04/24 | 1,344 | -0.88% | 15,751 |
23/04/24 | 1,356 | -3.38% | 23,309 |
22/04/24 | 1,403 | +6.39% | 36,416 |
Delayed Quote Bombay S.E., April 26, 2024 at 11:00 am
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+5.14% | 103B | |
-5.63% | 63.04B | |
+39.52% | 39.06B | |
+12.91% | 37.58B | |
+7.41% | 33.24B | |
+6.85% | 19.22B | |
+12.86% | 16.83B | |
+16.93% | 14.96B | |
+7.73% | 15.03B |
- Stock Market
- Equities
- EPIGRAL Stock
- EPIGRAL Stock